Valuation Beijing Beilu Pharmaceutical Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 30/09/2026			5-day change	1st Jan Change
9.560 ^CNY	+1.92%		-2.85%	+20.40%

09-20	Beijing Beilu Pharmaceutical Co., Ltd.(XSEC:300016) added to S&P Global BMI Index	CI
09-15	Beijing Beilu Pharmaceutical Co., Ltd. Approves Interim Profit Distribution Plan on A Shares for 2026, Payable on 23 September 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	4,727	4,523	3,208	3,503	3,050	4,469
Change	-	-4.32%	-29.09%	9.2%	-12.92%	46.53%
Enterprise Value (EV) ¹	4,417	4,204	3,088	3,545	3,239	4,300
Change	-	-4.82%	-26.55%	14.81%	-8.63%	32.77%
P/E	26.6x	36.7x	326x	-47.5x	207x	44.1x
PBR	2.71x	2.44x	1.81x	2.12x	1.83x	1.98x
PEG	-	-1.2x	-3.5x	0x	-2x	0x
Capitalization / Revenue	5.71x	5.36x	4.19x	3.93x	3.1x	3.71x
EV / Revenue	5.34x	4.98x	4.03x	3.98x	3.29x	3.57x
EV / EBITDA	24.6x	24.2x	44.7x	150x	22.6x	23.5x
EV / EBIT	32.2x	37.7x	-603x	-62.4x	60.8x	48.9x
EV / FCF	-1,039x	-34.3x	-52.9x	-20.1x	-134x	-25.5x
FCF Yield	-0.1%	-2.92%	-1.89%	-4.97%	-0.75%	-3.93%
Dividend per Share ²	0.06	0.07	0.07	-	0.05	-
Rate of return	0.63%	0.76%	1.07%	-	0.81%	-
EPS ²	0.36	0.25	0.02	-0.15	0.03	0.18
Distribution rate	16.7%	28%	350%	-	167%	-
Net sales ¹	827.3	843.9	765.9	890.7	983.6	1,205
EBITDA ¹	179.7	173.6	69.09	23.6	143.4	182.7
EBIT ¹	137.3	111.4	-5.124	-56.82	53.24	87.86
Net income ¹	174.7	125	11.21	-71.76	13.65	92.73
Net Debt ¹	-310.6	-319.3	-120	42.28	189.1	-168.8
Reference price ²	9.560	9.180	6.520	7.120	6.200	7.940
Nbr of stocks (in thousands)	494,494	492,718	491,956	491,935	491,935	562,873
Announcement Date	18/03/21	29/03/22	23/04/23	21/04/24	17/04/25	21/04/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BEIJING BEILU PHARMACEUTICAL CO., LTD.	-	-	-	-	829M
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.27x	2.29%	369.8B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%